Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)

v3.24.2.u1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022   $ 76,369,940 $ (75,734,927) $ 635,013
Beginning balance, shares at Dec. 31, 2022   1,086      
Issuance of common stock for exercise of stock options and vesting of restricted stock units   25,000 25,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period   2      
Issuance of common stock for public offering, net of issuance costs of $501,300   3,998,700 3,998,700
Stock Issued During Period, Shares, New Issues   267      
Stock-based compensation   1,682,827 1,682,827
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture   6      
Net loss   (30,327,663) (30,327,663)
Ending balance, value at Jun. 30, 2023   82,076,467 (106,062,590) (23,986,123)
Ending balance, shares at Jun. 30, 2023   1,361      
Beginning balance, value at Dec. 31, 2023 101,175,117 (120,806,138) (19,631,021)
Beginning balance, shares at Dec. 31, 2023 10,305      
Issuance of common stock for exercise of pre-funded warrants $ 0 $ 0 0 0 0
Issuance of common stock for exercise of pre-funded warrants, shares   739      
Issuance of common stock for exercise of Series A warrants 17,352,653 17,352,653
Issuance of common stock for exercise of Series A warrants, shares   138,593      
Proceeds received for exercise of buydown warrants 3,500 3,500
Proceeds received for exercise of buydown warrants, shares   78      
Common stock issued for conversion of convertible notes 7,395,907 7,395,907
Common stock issued for conversion of convertible notes, shares   39,762      
Conversion of Convertible Notes 24,716,118 24,716,118
Conversion of Convertible Notes, shares 24,698        
Conversion of Preferred Stock for common stock $ 0 $ 15 (15) 0 0
Conversion of preferred stock for common stock, shares (18,323) 1,244,081      
Issuance of common stock for exercise of Series B Warrants $ 1 1
Issuance of common stock for exercise of Series B Warrants, shares   117,605      
Reclassification of warrant liability to equity 3,405,662 3,405,662
Proceeds received for Issuance of warrants with May 2024 Notes, net of issuance costs of $111,194 1,023,200 1,023,200
Stock-based compensation 285,829 285,829
Common stock issued for reverse stock split due to rounding 0 $ 0 0 0 0
Common stock issued for reverse stock split due to rounding, shares   91,522      
Net loss (26,654,462) (26,654,462)
Ending balance, value at Jun. 30, 2024 $ 16 $ 155,357,971 $ (147,460,600) $ 7,897,387
Ending balance, shares at Jun. 30, 2024 6,375 1,642,685